Publications by authors named "Alan A Cohen"

Article Synopsis
  • - Aging brings about complex changes in energy metabolism, where damaged cells increase energy demands, but overall energy expenditure in the body stays stable or decreases.
  • - The brain plays a crucial role in managing energy resources; as tissues age and accumulate damage, the brain activates energy conservation responses to cope with lower energy availability.
  • - The proposed brain-body energy conservation (BEC) model of aging discusses the costs of cellular aging, the brain's perception of increased energy needs, and how external stressors or interventions can alter aging patterns.
View Article and Find Full Text PDF

It is becoming highly accepted that aging, age-related diseases, and geriatric healthcare can move forward if reductionist research is complemented by integrative research uniting knowledge on specific aging mechanisms, multiple biomedical, social, psychological, lifestyle, and environmental factors and their interactions. In this special issue, we present exciting papers that illustrate how complexity science theory and practice can be applied to aging research and provide a better understanding and quantification of healthy aging and vulnerability to disease. Recent insights on biomarkers, clocks of aging, frailty, and resilience are covered and studied in interaction with a dynamic multiscale perspective.

View Article and Find Full Text PDF

Energy transformation capacity is generally assumed to be a coherent individual trait driven by genetic and environmental factors. This predicts that some individuals should have high and others low mitochondrial oxidative phosphorylation (OxPhos) capacity across organ systems. Here, we test this assumption using multi-tissue molecular and enzymatic activities in mice and humans.

View Article and Find Full Text PDF
Article Synopsis
  • Biomarkers of aging (BOA) are special measurements that can help scientists understand how old someone is on a biological level and how this changes with treatments.
  • Recently, many new BOA have been discovered that could really help people live healthier lives as they age, but there are some problems getting these ideas into actual medical practice.
  • Experts found six main challenges that are stopping BOA from being used more widely and suggested ways to make them better, such as ensuring they are easy to access and useful for everyone.
View Article and Find Full Text PDF
Article Synopsis
  • Early warning signs (EWSs) can detect significant changes in a system's state, like critical transitions, through various statistical measures, with no clear consensus on the best method among several proposed EWSs.
  • In a study of 763 hemodialyzed patients, 15 different EWSs were compared based on their ability to predict mortality, revealing that variance-based EWSs were more effective than autocorrelation-based ones in indicating trends before death.
  • Although combining multiple indices improved predictive accuracy slightly, the overall effectiveness of individual indicators remained questionable, suggesting that the variety of signals could be reflecting either measurement errors or the complexity of the underlying system dynamics.
View Article and Find Full Text PDF
Article Synopsis
  • The search for biomarkers that measure biological aging, especially 'omic'-based ones, has gained momentum, aiming to predict aging outcomes and assess interventions for healthy aging.
  • There is currently no agreement on the best methods to validate these aging biomarkers before using them in clinical settings.
  • The review emphasizes the need for systematic validation, which can enhance the reliability and effectiveness of aging biomarkers in clinical research and trials focused on longevity.
View Article and Find Full Text PDF

Randomized controlled trials (RCTs) have traditionally been considered the gold standard for medical evidence. However, in light of emerging methodologies in data science, many experts question the role of RCTs. Within this context, experts in the USA and Canada came together to debate whether the primacy of RCTs as the gold standard for medical evidence, still holds in light of recent methodological advances in data science and in the era of big data.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates protein leverage (PL), a phenomenon where people eat more to reach a protein intake goal, which may contribute to obesity, especially in older adults.
  • A cohort of 1,699 older adults (ages 67-84) was analyzed, revealing that over half had obesity; the study found a significant relationship where increased protein intake led to lower total energy intake (TEI).
  • While there was clear evidence of PL affecting TEI, no significant link was found between TEI and body mass index (BMI), possibly due to age-related factors like body composition changes.
View Article and Find Full Text PDF

Background: A large body of literature associated extra virgin olive oil (EVOO) consumption with low risk of cardiovascular disease and mortality. However, findings from clinical trials related to EVOO consumption on blood pressure, lipid profile, and anthropometric and inflammation parameters are not univocal.

Objectives: The aim of this systematic review and meta-analysis was to evaluate the effect of EVOO consumption on cardiometabolic risk factors and inflammatory mediators.

View Article and Find Full Text PDF

Background: With two well-validated aging measures capturing mortality and morbidity risk, this study examined whether and to what extent aging mediates the associations of unhealthy lifestyles with adverse health outcomes.

Methods: Data were from 405,944 adults (40-69 years) from UK Biobank (UKB) and 9972 adults (20-84 years) from the US National Health and Nutrition Examination Survey (NHANES). An unhealthy lifestyles score (range: 0-5) was constructed based on five factors (smoking, drinking, physical inactivity, unhealthy body mass index, and unhealthy diet).

View Article and Find Full Text PDF
Article Synopsis
  • The growth of aging biology research is focusing on finding and assessing longevity interventions for humans, making biomarkers of aging essential tools for these efforts.
  • A lack of standards and consensus on what makes a reliable aging biomarker currently limits their development and application in clinical settings.
  • The article proposes a framework for categorizing aging biomarkers, discussing validation processes, and identifying challenges that need future research to facilitate their use in clinical trials and practices.
View Article and Find Full Text PDF

Introduction: Clinically, Alzheimer's disease (AD) is a syndrome with a spectrum of various cognitive disorders. There is a complete dissociation between the pathology and the clinical presentation. Therefore, we need a disruptive new approach to be able to prevent and treat AD.

View Article and Find Full Text PDF

Background: A decade ago, we proposed an index of physiological dysregulation based on Mahalanobis distance (DM) that measures how far from the norm an individual biomarker profile is. While extensive validation has been performed, focus was mostly on Western populations with little comparison to developing countries, particularly at a physiological system level. The degree to which the approach would work in other sociocultural contexts and the similarity of dysregulation signatures across diverse populations are still open questions.

View Article and Find Full Text PDF

Age-related social biases - ageism - are developed at an early age. Interventions to counter ageism have been identified but little is known about their mechanisms, particularly in children. This study aimed to provide a comprehensive understanding of which interventions in youths are most effective, under which circumstances, how, and with what outcomes.

View Article and Find Full Text PDF

Having made substantial progress understanding molecules, cells, genes and pathways, aging biology research is now moving toward integration of these parts, attempting to understand how their joint dynamics may contribute to aging. Such a shift of perspective requires the adoption of a formal complex systems framework, a transition being facilitated by large-scale data collection and new analytical tools. Here, we provide a theoretical framework to orient researchers around key concepts for this transition, notably emergence, interaction networks and resilience.

View Article and Find Full Text PDF

Background: Vitamin B-12 deficiency can result in irreversible neurologic damages. It is most prevalent among older adults (∼5%-15%), mainly due to impaired absorption. Vitamin B-12 bioavailability varies between food sources, so their importance in preventing deficiency may also vary.

View Article and Find Full Text PDF

Increased intra-individual variability of a variety of biomarkers is generally associated with poor health and reflects physiological dysregulation. Correlations among these biomarker variabilities should then represent interactions among heterogeneous biomarker regulatory systems. Herein, in an attempt to elucidate the network structure of physiological systems, we probed the inter-variability correlations of 22 biomarkers.

View Article and Find Full Text PDF

Recent proteogenomic approaches have led to the discovery that regions of the transcriptome previously annotated as non-coding regions [i.e., untranslated regions (UTRs), open reading frames overlapping annotated coding sequences in a different reading frame, and non-coding RNAs] frequently encode proteins, termed alternative proteins (altProts).

View Article and Find Full Text PDF

Background: Little is known about how normal variation in dietary patterns in humans affects the ageing process. To date, most analyses of the problem have used a unidimensional paradigm, being concerned with the effects of a single nutrient on a single outcome. Perhaps then, our ability to understand the problem has been complicated by the fact that both nutrition and the physiology of ageing are highly complex and multidimensional, involving a high number of functional interactions.

View Article and Find Full Text PDF

People exposed to adverse childhood experiences (ACEs) suffer from an increased risk of chronic disease and shorter lifespan. These individuals also tend to exhibit accelerated reproductive development and show signs of advanced cellular aging as early as childhood. These observations suggest that ACEs may accelerate biological processes of aging through direct or indirect mechanisms; however, few population-based studies have data to test this hypothesis.

View Article and Find Full Text PDF

Critical transition theory suggests that complex systems should experience increased temporal variability just before abrupt state changes. We tested this hypothesis in 763 patients on long-term hemodialysis, using 11 biomarkers collected every two weeks and all-cause mortality as a proxy for critical transitions. We find that variability-measured by coefficients of variation (CVs)-increases before death for all 11 clinical biomarkers, and is strikingly synchronized across all biomarkers: the first axis of a principal component analysis on all CVs explains 49% of the variance.

View Article and Find Full Text PDF

Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals. These differences are often considered to be a key cause of age-associated diseases as well as decreased vaccine responses in humans. The most often cited vaccine failure is seasonal influenza, but, while it is usually the case that the efficiency of this vaccine is lower in older than younger adults, this is not always true, and the reasons for the differential responses are manifold.

View Article and Find Full Text PDF

Background: We have previously developed and validated a biomarker-based metric of overall health status using Mahalanobis distance (DM) to measure how far from the norm of a reference population (RP) an individual's biomarker profile is. DM is not particularly sensitive to the choice of biomarkers; however, this makes comparison across studies difficult. Here we aimed to identify and validate a standard, optimized version of DM that would be highly stable across populations, while using fewer and more commonly measured biomarkers.

View Article and Find Full Text PDF